Familial Hemophagocytic Lymphohistiocytosis Due to PRF1 Mutation Triggered by Enterovirus

Abstract

Get full access to this article

View all access options for this article.

References

Ponnatt

Lilley

Mirza

KM.

Hemophagocytic lymphohistiocytosis. Arch Pathol Lab Med. 2022;146(4):507-519.

Henter

Horne

Aricó

, et al. HLH-2004: diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis. Pediatr Blood Cancer. 2007;48(2):124-131.

Ehl

Astigarraga

von Bahr Greenwood

, et al. Recommendations for the use of etoposide-based therapy and bone marrow transplantation for the treatment of HLH: consensus statements by the HLH Steering Committee of the Histiocyte Society. J Allergy Clin Immunol Pract. 2018;6(5):1508-1517.

Hardman

Tukur

Waruiru

Enterovirus-associated HLH: addition of anakinra to IVIG and corticosteroids. J Clin Immunol. 2019;39(4):373-375.

Horne

Ramme

Rudd

, et al. Characterization of PRF1, STX11 and UNC13D genotype-phenotype correlations in familial hemophagocytic lymphohistiocytosis. Br J Haematol. 2008;143:75-83.

Molleran Lee

Villanueva

Sumegi

, et al. Characterisation of diverse PRF1 mutations leading to decreased natural killer cell activity in North American families with haemophagocytic lymphohistiocytosis. J Med Genet. 2004;41:137-144.